Henry H. Armstrong Associates’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-6,113
Closed -$378K 59
2023
Q3
$378K Sell
6,113
-50
-0.8% -$3.16K 0.04% 45
2023
Q2
$364K Buy
6,163
+855
+16% +$54.4K 0.04% 45
2023
Q1
$392K Buy
5,308
+825
+18% +$63.7K 0.05% 46
2022
Q4
$327K Buy
4,483
+135
+3% +$10.7K 0.04% 49
2022
Q3
$363K Buy
4,348
+190
+5% +$16.3K 0.05% 51
2022
Q2
$331K Buy
+4,158
New +$404K 0.04% 51

Other funds holding NTR

Henry H. Armstrong Associates's NTR Position: Q4 2023 in Review

Henry H. Armstrong Associates sold out of Nutrien (NTR) in Q4 2023, closing a stake of 6,113 shares — an estimated $378K sold.

Henry H. Armstrong Associates first reported a position in NTR in Q2 2022 and held it in 6 quarters. The position peaked at $392K in Q1 2023. 639 funds tracked by Wall St. Rank hold NTR as of Q4 2023.

  • Henry H. Armstrong Associates reported no remaining Nutrien position as of Q4 2023 after selling out during the quarter.
  • Henry H. Armstrong Associates sold 6,113 Nutrien shares in Q4 2023, an estimated $378K.
  • Henry H. Armstrong Associates first reported a position in Nutrien in Q2 2022 and held it in 6 quarters.
  • Henry H. Armstrong Associates's Nutrien position peaked at $392K in Q1 2023.
  • 639 funds tracked by Wall St. Rank held Nutrien as of Q4 2023.

Based on Henry H. Armstrong Associates's 13F filing for Q4 2023, filed 11 Jan 2024.